Archer, FL, United States of America

Noel K Maclaren

This inventor holds 10 USPTO granted patents, plus 1 CIPO patent. Top assignees: University of Florida Research Foundation Inc., Research Corporation Technologies, Inc., The United States of America as Represented by the Department of Health. Active years: 1994-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noel K Maclaren. Retrieved from https://idiyas.com/inventor/noel-k-maclaren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 58(Granted Patents)


Location History:

  • Archer, FL (US) (1994 - 2001)
  • Gainesville, FL (US) (1999 - 2002)

Company Filing History:


Years Active: 1994-2002

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Noel K Maclaren

Introduction

Noel K Maclaren is a prominent inventor based in Archer, FL (US), known for his significant contributions to the field of diabetes research. With a total of 10 patents, Maclaren has developed innovative methods and compositions that aim to improve the detection and treatment of insulin-dependent diabetes.

Latest Patents

Among his latest patents, Maclaren has introduced groundbreaking methods for the detection of insulin-dependent diabetes. One notable invention is focused on providing an effective and reliable substitute for the currently employed ICA assay for diabetes. This method allows for the detection of autoantibodies to both GAD and IA-2 auto-antigens, resulting in a chemical assay with improved reliability. Additionally, these antigens may be utilized in therapeutic regimens aimed at achieving immune tolerance, thereby ameliorating the clinical condition. Another significant patent concerns a novel process for the early detection of insulin-dependent diabetes mellitus (IDD). This innovative process enables the detection of IDD onset before clinical symptoms appear by identifying a highly specific autoantibody in a biological fluid sample. Furthermore, the patent describes novel treatments for the prevention of IDD.

Career Highlights

Throughout his career, Maclaren has worked with esteemed organizations such as the University of Florida Research Foundation and Research Corporation Technologies, Inc. His work has significantly advanced the understanding and management of diabetes, making him a key figure in this vital area of research.

Collaborations

Maclaren has collaborated with notable individuals in the field, including Mark A Atkinson and Abner L Notkins. These collaborations have further enriched his research and contributed to the development of innovative solutions for diabetes detection and treatment.

Conclusion

Noel K Maclaren's contributions to diabetes research through his patents and collaborations highlight his dedication to improving healthcare outcomes. His innovative methods for detection and treatment continue to pave the way for advancements in the management of insulin-dependent diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…